Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- Check5 days agoChange DetectedModerna has been recognized as a Top Employer by Science for the tenth consecutive year as of October 24, 2024.SummaryDifference2%
- Check12 days agoChange DetectedModerna has announced that it will report its third quarter 2024 financial results on November 7, 2024.SummaryDifference2%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedModerna has made significant updates, including the appointment of Abbas Hussain to its Board of Directors and the initiation of a pivotal Phase 3 trial for its mRNA Norovirus vaccine, alongside a joint agreement with Cenra Healthcare to promote its mRNA respiratory vaccine portfolio in Taiwan.SummaryDifference6%
- Check41 days agoChange DetectedModerna has received Health Canada approval for an updated COVID-19 vaccine targeting the KP.2 variant for ages six months and older, and highlighted progress and strategic priorities during their R&D Day.SummaryDifference4%
- Check48 days agoChange DetectedThe website has updated the price to $79.28 and reported significant developments regarding Moderna, including the receipt of a Drug Establishment License from Health Canada and a positive opinion from the EMA for its COVID-19 mRNA vaccine targeting the JN.1 variant.SummaryDifference5%
- Check56 days agoChange DetectedModerna has received regulatory approvals for its updated COVID-19 vaccine targeting the SARS-COV-2 variant JN.1 in both the UK and Taiwan, alongside launching a national awareness campaign to promote vaccination.SummaryDifference7%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.